Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies ...

Capsida Biotherapeutics ("Capsida") today announced that AbbVie has exercised an option for the first neurodegenerative ...

Capsida Biotherapeutics yesterday revealed US pharma major AbbVie has exercised an option for the first neurodegenerative ...

THOUSAND OAKS, Calif., Nov. 25, 2024 /PRNewswire/ -- Capsida Biotherapeutics ("Capsida"), a leading fully integrated next-generation gene therapy company developing treatments for rare and common ...

Capsida Biotherapeutics is a fully integrated gene therapy company with a central nervous system (CNS) pipeline consisting of disease modifying and potentially curative treatments for rare and ...

Nov. 12, 2024 /PRNewswire/ -- Capsida Biotherapeutics ("Capsida") today announced new preclinical data for CAP-004, a potential best-in-class systemically administered next-generation gene therapy ...

THOUSAND OAKS, Calif., Dec. 19, 2024 /PRNewswire/ -- Capsida Biotherapeutics ("Capsida"), leader in next-generation IV-administered central nervous system (CNS) gene therapies, today announced it ...

THOUSAND OAKS, Calif., Dec. 19, 2024 /PRNewswire/ -- Capsida Biotherapeutics ("Capsida"), leader in next-generation IV-administered central nervous system (CNS) gene therapies, today announced it will ...